Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged

As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched in China.

Scroll to Top